Kirsten M. Boberg
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Differences in immunosuppressive strategies for primary sclerosing cholangitis after liver transplantation.
Journal: Journal of hepatology
Published: February 09, 2026
Accurate detection of cholangiocarcinoma in primary sclerosing cholangitis using DNA methylation biomarkers in bile and plasma.
Journal: JHEP reports : innovation in hepatology
Published: December 15, 2025
Proctocolectomy with permanent ileostomy is associated with improved transplant-free survival in patients with PSC.
Journal: JHEP reports : innovation in hepatology
Published: May 10, 2025
Whole-exome sequencing reveals novel cancer genes and actionable targets in biliary tract cancers in primary sclerosing cholangitis.
Journal: Hepatology communications
Published: September 29, 2023
Rates of Second Tumor, Metastasis, and Death From Cutaneous Squamous Cell Carcinoma in Patients With and Without Transplant-Associated Immunosuppression.
Journal: JAMA dermatology
Published: July 19, 2023
Reply: The mucosal gut signature in primary sclerosing cholangitis before and after liver transplantation. Is the dysbiosis index really predictive for the recurrence of PSC?
Journal: Hepatology (Baltimore, Md.)
Published: January 30, 2023
A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation.
Journal: Hepatology (Baltimore, Md.)
Published: March 14, 2022
Defining Primary Sclerosing Cholangitis: Results From an International Primary Sclerosing Cholangitis Study Group Consensus Process.
Journal: Gastroenterology
Published: July 18, 2021
Early and accurate detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by methylation markers in bile.
Journal: Hepatology (Baltimore, Md.)
Published: December 15, 2020
Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing Cholangitis.
Journal: Clinical and translational gastroenterology
Published: October 08, 2020
Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease.
Journal: JHEP reports : innovation in hepatology
Published: March 30, 2020
Autotaxin activity predicts transplant-free survival in primary sclerosing cholangitis.
Journal: Scientific reports
Published: December 10, 2018
Last Updated: 09/26/2026